Comparison of GMA-Tulip and i-gel supraglottic airway devices in orthopedic trauma surgery: a randomized controlled trial Authors: Yuanlei Gao, Liwen Jiang, Qinghe Chen, Xiuyu Wang, Ningning Fang, Feihong Jin, Shaozhong Yang Published: 2026 ABSTRACT AbstractBackgroundAccurate supraglottic airway device (SAD) placement is essential in general anesthesia, particularly in patients with orthopedic trauma who demonstrate unique airway challenges. We compared the novel noninflatable GMA-Tulip with the established second-generation i-gel.MethodsIn this randomized controlled trial, 198 adult patients who underwent emergency or urgent orthopedic trauma surgery were randomly assigned to receive either the i-gel or the GMA-Tulip. The primary outcome was the rate of correct anatomical alignment (defined as a Grade I or II glottic view), assessed immediately after insertion by using a flexible videoscope. Secondary outcomes included the success rate and time of SAD insertion, oropharyngeal leak pressure (OLP), the ease and time of gastric tube placement, and postoperative complications.ResultsThe GMA-Tulip provided significantly better initial anatomical alignment than the i-gel (85.3% vs. 65.3%; risk difference 20.0%, 95% CI 7.8–31.5%; P = 0.001), with this significant advantage persisting at 60 min (81.3% vs. 56.6%; P = 0.001) and before device removal (77.4% vs. 53.2%; P < 0.001). Both devices demonstrated comparable overall insertion success rates (99% each) and median insertion times (14 s). OLPs measured at 10 min (in the neutral position and with head rotation) and at 60 min after insertion exhibited no significant between-group differences (all P > 0.05). The gastric tube placement time was shorter in the GMA-Tulip group (median time: 16.0 s vs. 21.0 s; P < 0.001). At 1 h postoperatively, the incidence of sore throat was lower in the GMA-Tulip group (23.7% vs. 33.0%; P = 0.026).ConclusionIn patients who underwent orthopedic trauma surgery, the GMA-Tulip consistently demonstrated superior anatomical alignment, facilitated easier and faster gastric tube placement, and reduced the incidence of early postoperative sore throat compared with the i-gel.Trial registrationChinese Clinical Trial Registry (ChiCTR2500104359). Registered on June 16, 2025.Graphical Abstract Supplementary InformationThe online version contains supplementary material available at 10.1186/s12871-026-04007-3.Keywords: Orthopedic trauma surgery, Supraglottic airway devices, GMA-Tulip, i-gel, Anatomical alignment, Oropharyngeal leak pressure Introduction Injuries represent a major global health challenge, contributing to substantial disability and socioeconomic burdens [1, 2]. Orthopedic trauma necessitating surgical intervention accounts for a significant proportion of major trauma care [3]. These patients often experience delayed gastric emptying secondary to pain, immobilization, and opioid analgesia [4, 5]. This scenario increases the risk of an occult full stomach, which, together with potential tissue edema and underlying cervical spine instability, leads to particular challenges regarding airway management [6]. Supraglottic airway devices (SADs) are widely used in general anesthesia because of their relative ease of insertion and favorable hemodynamic profile [7–10]. However, blind insertion can result in device malposition relative to laryngeal structures, thereby potentially compromising the ventilation seal and increasing the risks of gastric insufflation and postoperative pharyngeal complications [7, 11]. Given the specific airway challenges outlined above, the evaluation of SADs in orthopedic trauma patients necessitates careful patient selection. Consequently, this study was conducted in a carefully selected cohort from which patients with recognized contraindications to SAD use (e.g., predicted difficult airway, high aspiration risk, or suspected cervical spine instability) were excluded. Therefore, in this appropriate patient population, the achievement of precise alignment between the SAD and laryngeal anatomy is crucial for ensuring safe and effective ventilation. The i-gel™ (Intersurgical Ltd, Workingham, United Kingdom) is a well‑established second‑generation SAD featuring a non‑inflatable thermoplastic elastomer cuff designed for anatomical conformity, with its efficacy being supported by substantial clinical evidence [12, 13]. The GMA-Tulip (TianJin Medan Medical Corp., Tianjin, China) is a novel noninflatable SAD that employs an “anatomically adaptive wrapping” design. Its body conforms to perilaryngeal structures at body temperature, whereas bilateral projections engage the pyriform fossae to improve stability (eFigure 1). This design aims to provide a more precise seal with reduced mucosal pressure. Although preliminary studies have suggested potential benefits in elective elderly patients [14], robust evidence directly comparing its efficacy and safety with those of the i-gel in orthopedic trauma patients remains limited. Fiberoptic laryngoscopy enables the direct and objective assessment of SAD alignment relative to the glottis. This technique is recommended in contemporary airway management guidelines and represents a valuable tool for evaluating SAD performance [10, 15, 16]. Thus, to directly compare the clinical performance of the GMA-Tulip and i-gel in this carefully selected population of patients undergoing orthopedic trauma surgery using this objective assessment, we conducted this prospective randomized controlled trial. Methods Study design and participants This single-center, prospective, parallel-group, randomized controlled trial was conducted at Qilu Hospital of Shandong University. The study protocol was approved by the Medical Ethics Committee of the Qilu Hospital of Shandong University (KYLL-202502-002-01) and was registered at the Chinese Clinical Trial Registry (ChiCTR2500104359; registration date: June 16, 2025) before patient enrollment. All of the participants provided written informed consent prior to enrollment. The trial was conducted and reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines. A total of 198 patients aged 18–70 years with American Society of Anesthesiologists (ASA) physical statuses of I-III and body mass index (BMI) values of 18–35 kg/m² who were scheduled to undergo emergency or urgent orthopedic trauma surgery in the supine position under general anesthesia were enrolled. The following exclusion criteria were utilized: predicted difficult airway (LEMON score ≥ 3 or clear history of a difficult airway [9], high risk of aspiration (e.g., nonfasting status, symptomatic gastroesophageal reflux disease, morbid obesity, or suspected full stomach), known or suspected cervical spine instability, active upper respiratory tract infection, concomitant oral or maxillofacial trauma, inability to understand the study procedures or use pain scales, and concurrent participation in other clinical trials. Additionally, exclusions comprised pregnant women, patients with major internal organ injuries, and those with major concomitant soft tissue injuries in the head, neck, or chest region that could potentially distort upper airway anatomy or compromise airway management. Randomization and blinding Patients were randomly assigned at a 1:1 ratio to either the i-gel group (Group I) or the GMA-Tulip group (Group G) by using a computer-generated random number sequence. An independent statistician (who was not involved in recruitment, data collection, or analysis) generated the sequence and placed it in sequentially numbered, opaque sealed envelopes. Before the induction of anesthesia, a research assistant who was not involved in the subsequent assessments opened the envelope and informed the attending anesthesiologist of the assigned SAD type. Blinding of the operator was not feasible because of the distinct appearances and tactile properties of the two SADs. Although the assessors of the videoscopic views could potentially identify the devices based on image characteristics, they were blinded to all other patient information. The personnel assessing postoperative complications and the statisticians performing the final data analysis remained blinded to group allocation throughout the study. Anesthesia management and intervention Upon arrival in the operating room, all of the patients received standard monitoring, including electrocardiography, non-invasive blood pressure, pulse oximetry, end-tidal carbon dioxide (EtCO₂), and temperature monitoring. Gastric content was assessed via bedside ultrasound to confirm the absence of solid or significant liquid residue, in order to exclude an occult full stomach [17]. Anesthesia was induced with intravenous midazolam (0.03 mg/kg), sufentanil (0.5 µg/kg), etomidate (0.2 mg/kg), and rocuronium (0.6 mg/kg). Facemask ventilation was performed to ensure adequate preoxygenation. Following loss of the eyelash reflex and confirmation of satisfactory muscle relaxation, SAD insertion was performed by an attending anesthesiologist with extensive experience (> 500 prior insertions). The size of each SAD was selected according to the manufacturer’s weight-based guidelines (i-gel: size 2.5, 25–30 kg; size 3, 30–60 kg; size 4, 50–90 kg; size 5, > 90 kg; GMA-Tulip: size 2.5, 30–50 kg; size 3, 40–70 kg; size 4, 65–90 kg; size 5, > 90 kg). For patients with weights that were observed near a category boundary, the final size selection was based on the clinical judgment of the attending anesthesiologist. Prior to insertion, each device was adequately lubricated with a water-soluble gel. The insertion technique strictly adhered to the standard method outlined in the respective manufacturer’s instructions. Immediately after SAD placement, a flexible videoscope (PL-F400, UE Medical Corp., Zhejiang, China) was inserted through the airway tube to record the glottic view before initiating mechanical ventilation. The view was graded as follows [15, 18]: Grade I, vocal cords visible; Grade II, vocal cords and posterior epiglottis visible; Grade III, vocal cords and anterior epiglottis visible, < 50% visual obstruction of the epiglottis to the vocal cords; Grade IV, vocal cords and anterior epiglottis visible, > 50% visual obstruction of the epiglottis to the vocal cords; and Grade V, vocal cords not visible. For this study, Grade I and II views were defined as adequate alignment; Grade III and IV views were defined as suboptimal alignment; and the Grade V view was defined as alignment failure (eFigure 2). All of the videoscopic recordings were uniformly labeled and then independently assessed by three anesthesiologists who were blinded to group allocation. Disagreements between the first two assessors were resolved by the third assessor, who served as an arbitrator. Following the videoscopic assessment, manual ventilation was performed through the SAD. Successful insertion was defined as the observation of an adequate chest rise and a normal, sustained EtCO₂ waveform. A maximum of three insertion attempts were permitted. One attempt was defined as the passing of the SAD through the teeth (or gums in edentulous patients) into the oropharynx, with movements such as rotation, depth change, head/neck repositioning, or jaw thrusts being permitted. If effective ventilation could not be established after three attempts, insertion failure was determined. The patient was then withdrawn from the study, and the airway was managed according to clinical routine practices. Intraoperatively, volume-controlled ventilation (a tidal volume of 8 mL/kg based on ideal body weight) was used, and the respiratory rate was adjusted to maintain the EtCO₂ between 35 and 45 mmHg. Anesthesia was maintained with sevoflurane, remifentanil, and supplemental rocuronium as needed, with the bispectral index (BIS) being maintained between 40 and 60. At the end of surgery, all of the anesthetic agents were discontinued. Neuromuscular blockade was reversed pharmacologically in all patients. The SAD was removed upon full recovery of spontaneous breathing and consciousness, after which the patient was then transferred to the Post-Anesthesia Care Unit (PACU). Outcomes Primary outcome The primary outcome was the rate of correct anatomical alignment, which was defined as the proportion of patients with a Grade I or II glottic view assessed immediately after insertion by using flexible videoscopy. Secondary outcome measures Insertion-related indicatorsFirst-attempt and overall insertion success rates.Insertion time, which was defined as the time (in seconds) from when the operator picked up the SAD after the cessation of facemask ventilation until successful pharyngeal placement.Ease of insertion, which was scored by the operator by using a 4-point scale (1=no resistance, 2=mild resistance, 3=moderate resistance, and 4=unable to insert). Insertion-related indicatorsFirst-attempt and overall insertion success rates.Insertion time, which was defined as the time (in seconds) from when the operator picked up the SAD after the cessation of facemask ventilation until successful pharyngeal placement.Ease of insertion, which was scored by the operator by using a 4-point scale (1=no resistance, 2=mild resistance, 3=moderate resistance, and 4=unable to insert). First-attempt and overall insertion success rates. First-attempt and overall insertion success rates. Insertion time, which was defined as the time (in seconds) from when the operator picked up the SAD after the cessation of facemask ventilation until successful pharyngeal placement. Insertion time, which was defined as the time (in seconds) from when the operator picked up the SAD after the cessation of facemask ventilation until successful pharyngeal placement. Ease of insertion, which was scored by the operator by using a 4-point scale (1=no resistance, 2=mild resistance, 3=moderate resistance, and 4=unable to insert). Ease of insertion, which was scored by the operator by using a 4-point scale (1=no resistance, 2=mild resistance, 3=moderate resistance, and 4=unable to insert). Intraoperative dynamic assessmentRepeated videoscopic assessment of anatomical alignment at 60 minutes after SAD insertion (if permitted by surgery duration) and before the end of surgery (prior to SAD removal).Oropharyngeal leak pressure (OLP), which was measured at 10 and 60 minutes after SAD insertion. The measurement was performed by switching the anesthesia machine to manual ventilation mode, with the adjustable pressure-limiting valve set to 30 cmH₂O and a fresh gas flow of 3 L/min being utilized. The OLP was recorded as the airway pressure at which the pressure gauge became stabilized and an audible leak was detected at the patient's mouth [18–20]. Auscultation over the epigastrium confirmed the absence of gas entry into the stomach during each measurement. In a subset of eligible patients, after the initial OLP measurement was performed in the neutral position (10 min), the patient's head was sequentially rotated 30° and 45° to both the left and right, with the OLP being remeasured at each position to assess device stability. Intraoperative dynamic assessmentRepeated videoscopic assessment of anatomical alignment at 60 minutes after SAD insertion (if permitted by surgery duration) and before the end of surgery (prior to SAD removal).Oropharyngeal leak pressure (OLP), which was measured at 10 and 60 minutes after SAD insertion. The measurement was performed by switching the anesthesia machine to manual ventilation mode, with the adjustable pressure-limiting valve set to 30 cmH₂O and a fresh gas flow of 3 L/min being utilized. The OLP was recorded as the airway pressure at which the pressure gauge became stabilized and an audible leak was detected at the patient's mouth [18–20]. Auscultation over the epigastrium confirmed the absence of gas entry into the stomach during each measurement. In a subset of eligible patients, after the initial OLP measurement was performed in the neutral position (10 min), the patient's head was sequentially rotated 30° and 45° to both the left and right, with the OLP being remeasured at each position to assess device stability. Repeated videoscopic assessment of anatomical alignment at 60 minutes after SAD insertion (if permitted by surgery duration) and before the end of surgery (prior to SAD removal). Repeated videoscopic assessment of anatomical alignment at 60 minutes after SAD insertion (if permitted by surgery duration) and before the end of surgery (prior to SAD removal). Oropharyngeal leak pressure (OLP), which was measured at 10 and 60 minutes after SAD insertion. The measurement was performed by switching the anesthesia machine to manual ventilation mode, with the adjustable pressure-limiting valve set to 30 cmH₂O and a fresh gas flow of 3 L/min being utilized. The OLP was recorded as the airway pressure at which the pressure gauge became stabilized and an audible leak was detected at the patient's mouth [18–20]. Auscultation over the epigastrium confirmed the absence of gas entry into the stomach during each measurement. In a subset of eligible patients, after the initial OLP measurement was performed in the neutral position (10 min), the patient's head was sequentially rotated 30° and 45° to both the left and right, with the OLP being remeasured at each position to assess device stability. Oropharyngeal leak pressure (OLP), which was measured at 10 and 60 minutes after SAD insertion. The measurement was performed by switching the anesthesia machine to manual ventilation mode, with the adjustable pressure-limiting valve set to 30 cmH₂O and a fresh gas flow of 3 L/min being utilized. The OLP was recorded as the airway pressure at which the pressure gauge became stabilized and an audible leak was detected at the patient's mouth [18–20]. Auscultation over the epigastrium confirmed the absence of gas entry into the stomach during each measurement. In a subset of eligible patients, after the initial OLP measurement was performed in the neutral position (10 min), the patient's head was sequentially rotated 30° and 45° to both the left and right, with the OLP being remeasured at each position to assess device stability. Assessment of gastric tube placement Assessment of gastric tube placement Following the confirmation of adequate ventilation, the placement of a 12-Fr gastric tube through the dedicated gastric drainage channel of the SAD was attempted (with a maximum of two attempts being allowed). The success rate, insertion time (from the initiation of insertion until a predetermined marking on the tube reached the proximal end of the channel), and operator’s subjective ease-of-insertion score (using the same 4-point scale as above) were recorded. Exploratory measures To exploratively assess and compare the esophageal seal of the two SADs, changes in gastric content were dynamically monitored via bedside gastric ultrasonography. A low-frequency convex probe was used to obtain a standard cross-sectional image of the gastric antrum in the subxiphoid view at the following three time points: before anesthesia induction (to exclude an occult full stomach), immediately after successful SAD insertion (t1), and before device removal at the end of surgery (t2). The cross-sectional area (CSA) was measured, and the presence of gas artifacts was noted. The change in CSA (ΔCSA = CSA at t2 – CSA at t1) was calculated to reflect the potential accumulation of gastric contents (particularly gas) during mechanical ventilation. All ultrasound examinations were performed with the patient in the supine position to minimize risk in this trauma population [21]. Gas aspirated via the gastric tube during surgery (excluding gas that was immediately aspirated after tube placement) was also recorded. Safety and complications All intraoperative adverse events were recorded, including significant gas leakage (requiring device adjustment or change), partial airway obstruction, laryngospasm, bronchospasm, and oxygen desaturation (SpO₂ < 92%). Upon SAD removal, the device was inspected for the presence of blood or suspected gastric contents (aided by using visual inspection and pH paper). Postoperative complications, including sore throat (assessed by using a Numeric Rating Scale, NRS 0–10), dysphagia, hoarseness, and oral numbness, were recorded by researchers who were blinded to group allocation during follow-up visits in the PACU and at 24 h after surgery. Sample size calculation Based on previous studies [20, 22] and pilot observational data, we hypothesized a correct anatomical alignment rate of 70% for the i-gel group and 90% for the GMA-Tulip group. This assumed effect size was consistent with our pilot data and with prior comparative studies of second-generation SADs [20, 22], in which alignment rate differences of 15–25% were reported. Using a two-sided chi-square test (α = 0.05, power = 90%) in PASS 2023 software (NCSS, LLC, USA) with 1:1 allocation, 79 participants per group were required. To accommodate an estimated 20% attrition rate, 198 patients (99 per group) were enrolled. A post-hoc power analysis, which was based on the observed alignment rates (i-gel: 65.3%; GMA-Tulip: 85.3%), confirmed that the study retained greater than 90% power to detect the significant differences. Statistical analysis All of the statistical analyses were conducted by using R statistical software (version 4.4.1; R Foundation for Statistical Computing, Vienna, Austria). An independent statistician who was not involved in the trial performed the analyses. Continuous variables are presented as the mean (standard deviation) or median (interquartile range), and categorical variables are presented as the frequency (percentage). The balance of baseline characteristics between the groups was assessed by using descriptive statistics and the standardized mean difference (SMD). The primary outcome was analyzed in the per-protocol population, which included all patients who completed the primary outcome assessment. This population was chosen because the primary endpoint can only be assessed in patients who actually received the device. The chi-square test was used to compare the rate of correct anatomical alignment immediately after insertion between the groups. The relative risk (RR) with its 95% confidence interval (CI) was calculated as the primary measure of effect, and the risk difference (RD) with its 95% CI was also reported. Secondary outcomes were analyzed in patients with available data. Continuous variables were assessed for normality; those meeting normality assumptions were compared by using the independent samples t-test (with the mean difference and 95% CI being reported), whereas nonnormally distributed variables were analyzed by using the Mann-Whitney U test (with the median difference and 95% CI being reported). Unordered categorical variables were compared by using the chi-square test or Fisher’s exact test, with the RR or RD and 95% CI being calculated as appropriate. Adverse events were analyzed for all of the patients with successful SAD insertion. To indirectly evaluate the seal of the SAD at the esophageal inlet, we performed an exploratory analysis of intraoperative gastric ultrasound data. These data included the occurrence of intragastric gas after insertion and before removal, the change in the gastric antrum cross-sectional area (ΔCSA), and the proportion of patients from whom gas was aspirated via the gastric tube during surgery. No data were missing for the primary outcome or baseline characteristics in the per-protocol set. Missing data for the secondary outcomes were not imputed. To address potential bias from missing data, we conducted various post hoc validation and sensitivity analyses concerning. First, Intention-to-treat (ITT) and modified intention-to-treat (mITT) analyses were performed to assess the robustness of the primary findings. In the ITT analysis, patients who did not receive the assigned device were classified as alignment failure. The mITT analysis included all patients who attempted SAD insertion. Second, a binary logistic regression model was fitted to verify the robustness of the effect of SAD on alignment accuracy, adjusting for potential confounders such as device size, age, sex, BMI, LEMON score, surgery type, surgical site, anesthesia duration, and intraoperative head position changes. Third, the primary outcome was expanded from a binary classification (accurate/inaccurate) to an ordinal classification (Grade I–V scores). A generalized ordered logistic regression model was then used to compare the alignment scores between the groups. Then, to analyze the longitudinal change in anatomical alignment scores across three time points, a linear mixed-effects model was constructed. This model included random intercepts to account for within-subject correlation and was adjusted for the abovementioned covariates, thus allowing for the assessment of within-group trends and between-group differences. All of the statistical tests were two-sided, and a P value < 0.05 was considered to indicate statistical significance. Results Between July and December 2025, 619 patients who were scheduled for orthopedic trauma surgery were screened. Among these patients, 198 eligible patients were randomly assigned to the i-gel group (Group I, n = 99) or the GMA-Tulip group (Group G, n = 99). After randomization, two patients in Group I and three patients in Group G did not receive the intervention because of changes in the surgical plan, and one patient in Group I withdrew consent. Consequently, 96 patients in each group underwent attempted insertion of the assigned SAD. Ultimately, 95 patients in each group underwent successful SAD insertion and were included in the primary outcome analysis. In Group G, one patient with an asymptomatic epiglottic cyst that was identified during videoscopy was withdrawn from the study after initial data collection, in accordance with the safety protocol; additionally, one patient in each group was withdrawn because of an intraoperative change in the surgical procedure. A total of 187 patients completed all of the study procedures (Fig. 1). The last follow-up date was January 2, 2026. Baseline demographic and clinical characteristics were well balanced between the groups (Table 1, eTable 1). CONSORT flow diagram Table 1Baseline demographic and clinical characteristics of patientsCharacteristicsi- gel group(n = 95)GMA-Tulip group(n = 95)SMDAge, (y)45.0 (30.0–56.0)45.0 (35.5–56.0)0.056Males/females, n (%)59/36 (62.1/37.9)63/32 (66.3/33.7)0.088Height, (cm)169.4 (7.9)169.0 (8.3)0.047Weight, (kg)70.0 (64.0–77.0)70.0 (60.0–80.0)0.028BMI, (kg/m2)24.6 (22.2–27.3)24.3 (22.4–27.0)0.011Device size, n (%)0.076 328 (29.5)26 (27.4) 458 (61.1)58 (61.1) 59 (9.5)11 (11.6)ASA, n (%)0.190 Ⅰ16 (16.8)10 (10.5) Ⅱ70 (73.7)74 (77.9) Ⅲ9 (9.5)11 (11.6)Type, n (%)0.043 Urgent surgery57 (60.0)55 (57.9) Emergency surgery38 (40.0)40 (42.1)Surgery position, n (%)0.157 Trunk5 (5.3)4 (4.2) Upper limb6 (6.3)10 (10.5) Lower limb84 (88.4)81 (85.3)Surgical time120.0 (80.00–175.0)125.0 (72.5–172.5)0.004Anaesthesia time, min150.0 (104.5–204.0)147.00 (100.0–203.0)0.013Data are presented as mean (SD), median (interquartile range), or absolute number (percentage)Abbreviations: SMD Standardized Mean Difference, IQR Interquartile Range, ASA American Society of Anesthesiologists, BMI Body mass index Baseline demographic and clinical characteristics of patients Data are presented as mean (SD), median (interquartile range), or absolute number (percentage) Abbreviations: SMD Standardized Mean Difference, IQR Interquartile Range, ASA American Society of Anesthesiologists, BMI Body mass index Primary outcome The correct anatomical alignment rate (assessed via videoscopy immediately after SAD insertion) was significantly greater in Group G than in Group I (85.3% [81/95] vs. 65.3% [62/95]; RD: 20.0%, 95% CI: 7.8–31.5%; P = 0.001) (Table 2). Table 2Anatomical alignment and oropharyngeal seal performanceOutcomesi-gel group(N = 95)GMA-Tulip group(N = 95)Difference, %(95% CI)Relative risk(95% CI)P-valuePrimary outcomesInitial alignment assessment, n (%) Adequate62/95 (65.3)81/95 (85.3)20.0 (7.8 to 31.5)a1.31 (1.10 to 1.56)0.001 Suboptimal31/95 (32.6)14/95 (14.7) Failure2/95 (2.1)0/95 (0)Secondary outcomes60-min alignment assessmentb, n/N (%) Adequate43/76 (56.6)61/75(81.3)24.8 (10.0 to 38.1)a1.44 (1.14 to 1.81)0.001 Suboptimal31/76 (40.8)13/75(17.3) Failure2/76 (2.6)1/75(1.3)Pre-removal alignment assessmentc, n/N (%) Adequate50/94 (53.2)72/93 (77.4)24.2 (10.6 to 36.7)a1.46 (1.17 to 1.82)<0.001 Suboptimal42/94 (44.7)21/93 (22.6) Failure2/94 (2.1)0/93 (0.0)OLP, cmH2O 10-min post-insertiond23.0 (19.5–27.5)24.0 (19.0–29.0)1 (-3.0 to 3.0)e0.421 L30°23.0 (18.5–27.0)22.0 (16.3–28.0)-1 (-5.0 to 2.0)e0.401 L45°21.0 (16.0–27.0)20.0 (14.0–25.0)-1 (-6.0 to 2.0)e0.106 R30°23.0 (18.0–28.0)21.0 (16.0–27.0)-2 (-5.0 to 1.0)e0.091 R45°20.0 (16.0–25.5)19.0 (13.3–24.8)-1 (-5.0 to 2.0)e0.28660-min post-insertionb25.0 (21.0–28.0)26.0 (22.0–29.0)1 (-2.0 to 4.0)e0.203Data are presented as mean (SD), median (IQR), or absolute number (percentage)Abbreviations: SMD Standardized Mean Difference, IQR Interquartile Range, ASA American Society of Anesthesiologists, BMI Body mass indexAlignment grading scale with flexible videoscope: Adequate = Grade I (vocal cords fully visible) or II (only arytenoids visible); Suboptimal = Grade III (only epiglottis visible) or IV (epiglottis not visible); Failure = Grade V (insertion failure)aRisk difference (95% CI) for the GMA-Tulip group versus the i-gel groupbData were analyzed using cases with surgery time >60 mincData were analyzed using cases that completed the proceduredData were analyzed using cases that underwent lateral position testing at 10min post-insertion (i-gel, n=95; GMA-Tulip, n=94)eMedian difference (95% CI) between the i-gel group and GMA-Tulip group Anatomical alignment and oropharyngeal seal performance Data are presented as mean (SD), median (IQR), or absolute number (percentage) Abbreviations: SMD Standardized Mean Difference, IQR Interquartile Range, ASA American Society of Anesthesiologists, BMI Body mass index Alignment grading scale with flexible videoscope: Adequate = Grade I (vocal cords fully visible) or II (only arytenoids visible); Suboptimal = Grade III (only epiglottis visible) or IV (epiglottis not visible); Failure = Grade V (insertion failure) aRisk difference (95% CI) for the GMA-Tulip group versus the i-gel group bData were analyzed using cases with surgery time >60 min cData were analyzed using cases that completed the procedure dData were analyzed using cases that underwent lateral position testing at 10min post-insertion (i-gel, n=95; GMA-Tulip, n=94) eMedian difference (95% CI) between the i-gel group and GMA-Tulip group The videoscopic glottic view grading by the two primary assessors showed high inter-rater agreement (linear weighted Cohen’s κ = 0.899, 95% CI: 0.868–0.929, P < 0.001), confirming the reliability of the assessments. Secondary outcomes Anatomical alignment at 60 min and before device removal The superior anatomical alignment achieved with the GMA-Tulip upon insertion was sustained throughout the procedure. At the 60-minute assessment, the rate of adequate alignment was 81.3% (61/75) in Group G and 56.6% (43/76) in Group I (RD: 24.8%, 95% CI: 10.0–38.1%; P = 0.001). This difference persisted before device removal (77.4% [72/93] vs. 53.2% [50/94]; RD: 24.2%; 95% CI: 10.6–36.7%; P < 0.001). Notably, two patients in Group I demonstrated a Grade V view (no glottic structure visible) at all of the assessment time points, and one patient in Group G demonstrated a Grade V view at the 60-minute assessment; however, effective ventilation was maintained in all of these patients. Seal performance of the SADs The median OLP at 10 min after insertion was similar between the groups (Group I: 23.0 [IQR: 19.5–27.5] cmH₂O vs. Group G: 24.0 [19.0–29.0] cmH₂O; P = 0.421). No significant differences were observed in OLP at 60 min of ventilation or when the patient’s head was rotated 30° and 45° to either side (all P > 0.05; Table 2). Device insertion performance Both SADs demonstrated a high overall insertion success rate (99% each) and similar median insertion times (14 s). However, the operator-rated ease of insertion was better for the GMA-Tulip (P = 0.015). Insertion was subjectively graded as “no or mild resistance” more frequently in the GMA-Tulip group than in the i-gel group (94.8% vs. 80.2%; Table 3). Table 3Device and gastric tube insertion characteristicsCharacteristicsi-gel group(N = 96)GMA-Tulip group(N = 96)Difference, %(95% CI)Relative risk(95% CI)P-valueDevice Insertion CharacteristicsOverall insertion success, n (%)95 (99.0)95 (99.0)0 (-4.7 to 4.7)a1 (1 to 1)>0.99First-attempt insertion success, n (%)87 (90.6)91 (94.8)4.2 (-3.6 to 12.2)a1.05 (0.94 to 1.16)0.267Number of insertion attempts, n (%), (1/2/3)87/8/1(90.6/8.3/1.0)91/4/1(94.8/4.2/1.0)……0.684Insertion timeb, (s)14.0 (11.0–18.0)14.0 (11.0–16.0)0 (-3 to 1)c0.180Ease of device insertion, n (%)……0.015 No resistance34 (35.4)45 (46.9) Mild resistance43 (44.8)46 (47.9) Moderate resistance18 (18.8)4 (4.2) Inability to insert the device1 (1.0)1 (1.0)Gastric Tube Insertion CharacteristicsSuccessful insertion at first attempt, n/N (%)92/95 (96.8)94/94 (100.0)3.2 (1.3 to 8.9)a1.03 (0.98 to 1.09)0.246Ease of tube insertiond, n/N (%)……< 0.001 No resistance0/95 (0.0)37/94 (39.4) Mild resistance41/95 (43.2)52/94 (55.3) Moderate resistance51/95 (53.7)5/94 (5.3) Inability to insert the device3/95 (3.2)0/94 (0.0)Insertion timed, (s)21.0 (19.0–26.5)16.0 (11.3–18.0)-5 (-8 to -4)c< 0.001Data are presented as mean (SD), median (IQR), or absolute number (percentage)Abbreviations: CI Confidence interval, SD Standard deviation, IQR Interquartile rangeaRisk difference (95% CI) for the GMA-Tulip versus the i-gelbData were analyzed using cases with successful device placement (i-gel, n = 95; GMA-Tulip, n = 95)cMedian difference (95% CI) between the i-gel and GMA-TulipdData were analyzed using cases with successful gastric tube insertion (i-gel, n = 95; GMA-Tulip, n = 94) Device and gastric tube insertion characteristics 87/8/1 (90.6/8.3/1.0) 91/4/1 (94.8/4.2/1.0) Data are presented as mean (SD), median (IQR), or absolute number (percentage) Abbreviations: CI Confidence interval, SD Standard deviation, IQR Interquartile range aRisk difference (95% CI) for the GMA-Tulip versus the i-gel bData were analyzed using cases with successful device placement (i-gel, n = 95; GMA-Tulip, n = 95) cMedian difference (95% CI) between the i-gel and GMA-Tulip dData were analyzed using cases with successful gastric tube insertion (i-gel, n = 95; GMA-Tulip, n = 94) Gastric tube insertion performance Gastric tube placement was significantly faster in Group G than in Group I (16.0 [11.3–18.0] s vs. 21.0 [19.0–26.0] s; P < 0.001). The operator-assessed ease of insertion was also more favorably rated for the GMA-Tulip (P < 0.001; Table 3). Safety and postoperative complications No significant difference in the incidence of intraoperative adverse events (including air leakage or device displacement) was observed between the groups. At 1 h after surgery, the incidence of sore throat was significantly lower in Group G than in Goup I (23.7% vs. 33.0%; P = 0.026), with all reported pain being mild in nature (NRS ≤ 3). This difference was no longer statistically significant at 24 h after surgery. The incidence of other complications, such as dysphagia and hoarseness, were comparable between the groups (Table 4). Table 4Comparison of complications and adverse events between the i-gel and GMA-Tulip groupsTime Period / Eventi-gel group(N = 95)GMA-Tulip group(N = 95)Difference, %(95% CI)Relative risk(95% CI)P-valueDuring Maintenance Air leak, n/N (%)2/95 (2.1)1/95 (1.1)-1.1 (-6.4 to 3.9)NA> 0.99 Device displacement, n/N (%)3/95 (3.2)6/95 (6.3)3.2 (-3.5 to 10.3)2.00 (0.27 to 14.62)0.497 Device readjustment, n/N (%)3/95 (3.2)5/95 (5.3)2.1 (-4.4 to 8.9)1.67 (0.11 to 26.67)0.721Post-device removal Blood on device, n/N (%)5/94 (5.3)4/93 (4.3)-1.0 (-8.1 to 5.9)NA> 0.99 Gastric contents on device, n/N (%)4/94 (4.3)2/93 (2.2)-2.1 (-8.5 to 3.8)0.51 (0.02 to 14.12)0.682Recovery events in PACU Cough, n/N (%)2/94 (2.1)0/93 (0.0)-2.1 (-7.5 to 2.1)NA0.497 Retching, n/N (%)5/94 (5.3)1/93 (1.1)-4.2 (-10.9 to 1.4)0.20 (0.02 to 2.59)0.211 Breath-holding, n/N (%)5/94 (5.3)4/93 (4.3)-1.0 (-8.1 to 5.9)NA> 0.99 Oxygen desaturation, n/N (%)4/94 (4.3)1/93 (1.1)-3.2 (-9.5 to 2.2)0.25 (0.01 to 5.15)0.368 Suspected laryngospasm, n/N (%)0/94 (0.0)1/93 (1.1)1.1 (-3.0 to 5.8)NA0.497Follow-up Assessments1-h Postoperatively Sore throat, n/N (%)0.026 063/94 (67.0)71/93 (76.3) 111/94 (11.7)16/93 (17.2) 216/94 (17.0)4/93 (4.3) 34/94 (4.3)2/93 (2.2) Neck pain, n/N (%)0.059 094/94 (100.0)89/93 (95.7) 10/94 (0.0)3/93 (3.2) 20/94 (0.0)1/93 (1.1) Jaw pain, n/N (%)0.809 092/94 (97.9)90/93 (96.8) 12/94 (2.1)2/93 (2.2) 20/94 (0.0)1/93 (1.1)Dysphagia, n/N (%)3/94 (3.2)2/93 (2.2)-1.0 (-7.1 to 4.7)NA> 0.99Oral numbness, n/N (%)1/94 (1.1)2/93 (2.2)1.1 (-3.9 to 6.5)NA0.62Dysphonia, n/N (%)1/94 (1.1)2/93 (2.2)1.1 (-3.9 to 6.5)NA0.62Hoarseness, n/N (%)15/94 (16.0)8/93 (8.6)-7.4 (-17.1 to 2.2)0.54 (0.21 to 1.36)0.1324 h Postoperatively Sore throat, n/N (%)0.770 088/94 (93.6)88/93 (94.6) 16/94 (6.4)5/93 (5.4)-1.0 (-8.6 to 6.4)NA Hoarseness, n/N (%)1/94 (1.1)1/93 (1.1)0.01 (-4.8 to 4.8)NA> 0.99Subjects with ≥ 1 event, n/N (%)51/95 (53.7)39/95 (41.1)-12.6 (-26.1 to 1.5)0.76 (0.55–1.06)0.081Data are presented as n/N (%) unless otherwise specifiedAbbreviations: CI Confidence interval, NA Not applicable, PACU Post-anesthesia care unit, NRS Numeric Rating ScaleNA: The effect estimate (relative risk) could not be calculatedDenominators for outcomes are based on patients with successful device placement (N=95 per group). For recovery events in PACU and follow-up assessments, the denominators reflect available data at each time pointSore throat, neck pain, and jaw pain were assessed using an 11-point NRS, where 0 = no pain and 10 = worst imaginable pain. The table presents the number of patients reporting scores of 0, 1, 2, and 3 at the specified time point Comparison of complications and adverse events between the i-gel and GMA-Tulip groups Data are presented as n/N (%) unless otherwise specified Abbreviations: CI Confidence interval, NA Not applicable, PACU Post-anesthesia care unit, NRS Numeric Rating Scale NA: The effect estimate (relative risk) could not be calculated Denominators for outcomes are based on patients with successful device placement (N=95 per group). For recovery events in PACU and follow-up assessments, the denominators reflect available data at each time point Sore throat, neck pain, and jaw pain were assessed using an 11-point NRS, where 0 = no pain and 10 = worst imaginable pain. The table presents the number of patients reporting scores of 0, 1, 2, and 3 at the specified time point Exploratory analysis To indirectly evaluate the gastric seals of the two devices, intraoperative changes in gastric contents were monitored via gastric ultrasonography. No significant difference in the change in the gastric antrum cross-sectional area (ΔCSA) was detected between the groups during surgery (P = 0.410). Although a lower proportion of patients in the Group G exhibited intragastric gas prior to device removal compared to the Group I (21.4% vs. 34.5%), this difference did not achieve statistical significance (P = 0.052). Similarly, the proportion of patients from whom gas was aspirated via the gastric tube during surgery did not differ between the groups (P = 0.442; eTable 2). Post hoc analysis A series of post hoc analyses were conducted to verify the robustness of the primary outcome. First, the findings from both ITT (81.8% vs. 62.6%; P = 0.003) and mITT (84.4% vs. 64.6%; P = 0.002; eTable 3) analyses were consistent with the primary per-protocol analysis, confirming the robustness of the main results. Second, after adjusting for potential confounders by using multivariable binary logistic regression, the GMA-Tulip remained significantly associated with higher rates of correct anatomical alignment (OR range: 3.69–4.36; all P < 0.001; eTable 4). Third, analyses considering the glottic view grade as an ordinal variable (ordinal logistic regression) and assessing alignment scores longitudinally (linear mixed-effects model) consistently confirmed that the GMA-Tulip provided superior and more stable anatomical alignment throughout the procedure (eTable 5, 6). Furthermore, although female sex was identified as an independent predictor of good alignment (OR: 4.74, P = 0.021), no significant interaction was detected between device group and sex (eTable 7), thus indicating that the alignment advantage of the GMA-Tulip was consistent in both male and female patients. Discussion This randomized controlled trial demonstrated that in patients undergoing orthopedic trauma surgery, the novel GMA-Tulip achieved and maintained significantly better anatomical alignment with the glottis than the i-gel, as verified via videoscopy. Notably, this alignment advantage, however, did not yield higher oropharyngeal leak pressures, which were comparable between the devices. Nevertheless, the GMA-Tulip conferred distinct clinical advantages, including facilitated gastric tube placement and a reduced incidence of early postoperative sore throat. These findings suggest that the GMA-Tulip is a valuable alternative for airway management in this high-risk population. The quality of anatomical alignment and the effectiveness of functional sealing in SADs are complex factors. Specifically, they are modulated by multiple factors, including device design, patient anatomical variation, physiological state, and operator technique; moreover, they are not linearly related [23]. Although the initial correct alignment rate was significantly higher in the GMA-Tulip group, the measured seal pressures were comparable between the two devices. This discrepancy suggests that the oropharyngeal seal was less sensitive to the degree of anatomical alignment than the videoscopic view. We believe this is because noninflatable, anatomically contoured devices can oft achieve an effective seal through circumferential compression, even when the laryngeal inlet is not perfectly centered [7, 10, 18]. Although OLP reliably indicates an optimal SAD position, its sensitivity for detecting malposition is limited, as even suboptimal positioning can achieve an adequate seal via circumferential tissue compression [24]. However, superior anatomical alignment (when an adequate oropharyngeal seal is already established) may translate into a more uniform distribution of mucosal pressure and a reduced risk of localized high-pressure points. This mechanism could directly explain the lower incidence of early postoperative sore throat observed in the GMA-Tulip group in our study. Although OLP was similar between groups, better alignment with GMA-Tulip was associated with other clinical benefits, including shorter gastric tube insertion time, fewer sore throats at one hour postoperatively, and trends toward less intragastric gas accumulation. We recognize that no differences were found in ventilation or aspiration-related outcomes. This may partly reflect our sample size, which was powered for the primary endpoint, and the fact that we excluded high-risk patients who might be more likely to develop such events. Future work specifically targeting these outcomes would help clarify the clinical value of improved anatomical alignment. Therefore, in clinical practice, when patients at higher risks of aspiration are managed, a “satisfactory” leak pressure reading should not completely rule out the possibility of suboptimal videoscopic alignment, and direct or indirect anatomical assessment remains valuable. In addition, the potential influence of population-specific anatomy should be considered, although this hypothesis is speculative and was not specifically tested in the present study. The GMA-Tulip was designed by using anatomical data obtained from Asian populations, whereas many conventional SADs were developed primarily based on Caucasian anatomy [25, 26]. Given that our study included Chinese patients, the observed alignment advantage may partly reflect a better fit with local anatomical characteristics. This scenario suggests the potential suitability of the GMA-Tulip for Asian patients, although this hypothesis requires direct validation in ethnically diverse cohorts. The GMA-Tulip achieves precise anatomical alignment through its unique noninflatable cuff and anatomical sealing structure [14]. Its design features include: (1) an “anatomically adaptive wrap” enabled by a body temperature-activated gel-like body; (2) bilateral protrusions anchoring into the pyriform fossae; and (3) an equilateral triangular main stem that maximizes airway conduit space utilization (eFigure 1). This design ensures stable conformity to laryngeal structures; specifically, the distal dual convex surfaces oppose the pyriform fossae, the proximal cuff connects to the vallecula, the anterior portion wraps around the laryngeal inlet, and the posterior aspect is surrounded by the posterior pharyngeal wall, thereby forming an effective “mirror seal”14. The anatomical adaptability of the GMA-Tulip enables it to achieve more precise periglottic alignment while maintaining comparable sealing pressure, which may reduce tissue trauma to adjacent vessels and nerves. Due to its superior anatomical positioning, the device enhances periglottic sealing, thereby mitigating the risks of ventilation leakage and gastric insufflation. Furthermore, this performance aligns with the contemporary design philosophy for airway devices, which emphasizes low mucosal pressure and high anatomical conformity [8, 27]. The ease of gastric tube insertion represents another notable advantage of the GMA-Tulip in this study. The shorter insertion time and greater operator-perceived convenience directly stem from its design features. For example, the bilateral protrusions are anchored in the pyriform fossa to stabilize drainage channel alignment; moreover, the dual gastric drainage channels with larger internal diameters significantly reduce insertion resistance. For patients with orthopedic trauma, delayed gastric emptying due to pain, immobilization, and analgesics is a common occurrence [28], thus demonstrating the establishment of a reliable gastric decompression pathway as a critical factor for managing aspiration risk [17]. A recent network meta-analysis also explicitly identified reliable gastric drainage functionality in second-generation supraglottic airway devices as a key feature for reducing aspiration-related risks [13]. Therefore, the GMA-Tulip’s optimized design for gastric tube insertion efficiency provides practical operational convenience in clinical scenarios requiring rapid drainage. Although the absolute value of gastric tube insertion in preventing aspiration remains debated, in known high-risk situations, any measure that improves drainage efficiency demonstrates clinical justification [29]. Postoperative sore throat (POST) is a common discomfort that occurs after general anesthesia. Although it is often considered to be a minor complication, it directly affects patients’ early recovery experience and satisfaction [30]. Thus, the implementation of effective preventive measures in clinical practice is crucial. Recent meta-analytic evidence indicates that in adults undergoing abdominal-pelvic surgery, second-generation SADs significantly reduce the incidence of POST [31]. These findings suggest that the selection of appropriate airway management tools is an effective strategy for optimizing the perioperative experience and improving patient satisfaction. In this study, the GMA-Tulip group exhibited a lower POST incidence at 1 h after surgery. Although the pain was mild and the difference resolved within 24 h, this early benefit remains valuable, as immediate postoperative discomfort is a key component of patients’ overall healthcare experience [32, 33]. The occurrence of POST is closely associated with the mechanical pressure exerted on the pharyngeal mucosa [32]. We speculate that the superior anatomical alignment of the GMA-Tulip may result in more conforming contact with the laryngeal structures and more uniform pressure distribution, thereby avoiding localized high-pressure points caused by alignment deviation and reducing mucosal injury. In addition, other factors such as device material properties and insertion dynamics may also contribute to the observed difference. This potential mechanism ranging from “precise alignment” to “pressure optimization” to “tissue protection” aligns with findings of differences in pharyngeal mucosal blood perfusion associated with different airway devices [34]. Furthermore, the emerging role of video laryngeal masks, which enable direct visualization during insertion, may help avoid the limitations associated with blind insertion of conventional second-generation SADs. This technology represents a promising advancement in airway management that warrants further investigation [35]. Limitations This study has several limitations. First, as this was a single-center study with all of the device insertions being performed by one experienced operator. This design was chosen intentionally to minimize operator-related variability, so that we could focus on comparing the intrinsic performance of the two devices. It is possible that the results would differ with less experienced operators, and the learning curve for the GMA-Tulip has not yet been systematically evaluated. The operator-reported ease of insertion is a subjective measure and may be influenced by individual experience and preference, which should be considered when interpreting these results. Second, although the sample size was adequate, a larger multicenter sample may help to more precisely evaluate some less frequent complications or subgroup differences. Third, complete blinding was not feasible. To minimize detection bias, we used three independent, blinded assessors for the primary outcome and kept the postoperative assessors and the statistician blinded. However, patients may still have reported sore throat with awareness of group assignment (through postoperative sensation or unintentional disclosure by staff), introducing potential reporting bias. Fourth, for patient safety, we excluded identifiable high-risk patients (e.g., non-fasting status, full stomach on gastric ultrasound, cervical spine instability, airway trauma). However, occult conditions may remain undetected, and we did not impose a fixed surgical duration limit, as the decision to use a SAD was made by the attending anesthesiologist, reflecting real-world practice. Therefore, our results should be interpreted as applicable to a selected trauma population deemed suitable for SAD use, and caution is warranted when extrapolating to higher-risk patients or prolonged surgeries. Finally, this study mainly focused on intraoperative and short-term outcomes and did not assess long-term airway sequelae. Conclusion In patients who underwent orthopedic trauma surgery, the GMA-Tulip consistently demonstrated superior anatomical alignment; facilitated easier and faster gastric tube placement; and significantly reduced the incidence of early postoperative sore throat. Therefore, the GMA-Tulip can be considered a practical and effective alternative for airway management in this patient population. Supplementary Information Supplementary Material 1. Acknowledgements The authors thank all the involved patients for their contributions to this trial. Authors’ contributions Yuanlei Gao: Writing – original draft, Visualization, Conceptualization. Liwen Jiang: Randomization. Ningning Fang: Visualization, Validation. Xiuyu Wang: Formal analysis, Data curation. Qinghe Chen: Investigation. Feihong Jin: Visualization, Conceptualization. Shaozhong, Yang: Writing – review & editing, Supervision, Funding acquisition, Project administration. Funding This study was supported by the Horizontal Research Project Funds of Shandong University (6010124214). The funding agencies did not conduct a peer review of the study protocol as part of the funding approval process. The study design, data collection, analysis, and manuscript preparation were independently completed by the authors. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Data availability The data supporting the findings of this study are not publicly available due to restrictions imposed by the Medical Ethics Committee of Qilu Hospital of Shandong University. However, de-identified individual participant data, the data dictionary, and statistical analysis code are available upon reasonable request via email to the corresponding author (200962001135@email.sdu.edu.cn). Access will be granted following review and approval of a research proposal, completion of a data use agreement, and approval by the ethics committee. Other study materials can be provided under the same terms. Declarations Ethics approval and consent to participate This prospective randomized controlled trial was approved by the Medical Ethics Committee of the Qilu Hospital of Shandong University (No. KYLL-202502-002-01) and was conducted in accordance with the principles of the Declaration of Helsinki. The trial was prospectively registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2500104359, June 16, 2025). Written informed consent was obtained from all participants. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Feihong Jin, Email: Jinfeihong0321@163.com. Shaozhong Yang, 200962001135@email.sdu.edu.cn. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement The data supporting the findings of this study are not publicly available due to restrictions imposed by the Medical Ethics Committee of Qilu Hospital of Shandong University. However, de-identified individual participant data, the data dictionary, and statistical analysis code are available upon reasonable request via email to the corresponding author (200962001135@email.sdu.edu.cn). Access will be granted following review and approval of a research proposal, completion of a data use agreement, and approval by the ethics committee. Other study materials can be provided under the same terms.